vs
Side-by-side financial comparison of Metalpha Technology Holding Ltd (MATH) and Prelude Therapeutics Inc (PRLD). Click either name above to swap in a different company.
Metalpha Technology Holding Ltd is the larger business by last-quarter revenue ($12.0M vs $6.5M, roughly 1.8× Prelude Therapeutics Inc). Metalpha Technology Holding Ltd runs the higher net margin — -24.0% vs -303.5%, a 279.5% gap on every dollar of revenue. On growth, Prelude Therapeutics Inc posted the faster year-over-year revenue change (116.7% vs -39.0%).
Metalpha Technology Holding LtdMATHEarnings & Financial Report
Metalpha Technology Holding Ltd is a global fintech firm specializing in digital asset wealth management, institutional-grade crypto investment services, and Web3 ecosystem infrastructure support. It serves professional investors, financial institutions, and high-net-worth clients across Asia, North America and Europe, with core segments including structured digital asset products, risk management solutions and DeFi technology development.
MATH vs PRLD — Head-to-Head
Income Statement — Q3 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $12.0M | $6.5M |
| Net Profit | $-2.9M | $-19.7M |
| Gross Margin | 28.3% | — |
| Operating Margin | -24.2% | -314.1% |
| Net Margin | -24.0% | -303.5% |
| Revenue YoY | -39.0% | 116.7% |
| Net Profit YoY | -147.7% | 38.9% |
| EPS (diluted) | $-0.07 | $-0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | $12.0M | $6.5M | ||
| Q1 25 | $24.8M | — | ||
| Q3 24 | $19.7M | $3.0M |
| Q3 25 | $-2.9M | $-19.7M | ||
| Q1 25 | $9.8M | — | ||
| Q3 24 | $6.0M | $-32.3M |
| Q3 25 | 28.3% | — | ||
| Q1 25 | 85.7% | — | ||
| Q3 24 | 49.5% | — |
| Q3 25 | -24.2% | -314.1% | ||
| Q1 25 | 39.3% | — | ||
| Q3 24 | 38.9% | -1145.9% |
| Q3 25 | -24.0% | -303.5% | ||
| Q1 25 | 39.6% | — | ||
| Q3 24 | 30.7% | -1075.7% |
| Q3 25 | $-0.07 | $-0.26 | ||
| Q1 25 | $0.25 | — | ||
| Q3 24 | $0.16 | $-0.43 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $10.1M | $55.0M |
| Total DebtLower is stronger | $101.2K | — |
| Stockholders' EquityBook value | $35.1M | $58.5M |
| Total Assets | $413.8M | $94.8M |
| Debt / EquityLower = less leverage | 0.00× | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $10.1M | $55.0M | ||
| Q1 25 | $6.9M | — | ||
| Q3 24 | $3.8M | $153.6M |
| Q3 25 | $101.2K | — | ||
| Q1 25 | $188.0K | — | ||
| Q3 24 | $275.1K | — |
| Q3 25 | $35.1M | $58.5M | ||
| Q1 25 | $36.6M | — | ||
| Q3 24 | $25.3M | $156.4M |
| Q3 25 | $413.8M | $94.8M | ||
| Q1 25 | $246.8M | — | ||
| Q3 24 | $237.2M | $197.2M |
| Q3 25 | 0.00× | — | ||
| Q1 25 | 0.01× | — | ||
| Q3 24 | 0.01× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $3.3M | $-19.1M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $3.3M | $-19.1M | ||
| Q1 25 | $16.2M | — | ||
| Q3 24 | $-16.1M | $-27.3M |
| Q3 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | $-27.4M |
| Q3 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | -912.0% |
| Q3 25 | — | 0.0% | ||
| Q1 25 | — | — | ||
| Q3 24 | — | 2.1% |
| Q3 25 | — | — | ||
| Q1 25 | 1.64× | — | ||
| Q3 24 | -2.66× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
